Fintech

How new technologies are empowering financial advisers

From artificial intelligence to analytics advances, fintech is changing the wealth management industry. Pexels

Today's technologies have changed the wealth management industry by providing innovative tools to help empower clients and may allow a more productive and beneficial working relationship between financial advisers and their clients. Whether someone is saving for retirement, college, a new business, or travel, I have found that with new technologies, I am better able to communicate with my clients and help them meet their holistic investment goals.

It is an exciting time for wealth management. The industry is on the cutting edge of creating and adopting new technologies and innovations to empower financial advisers to engage and manage our clients' assets. Technologies such as artificial intelligence and risk analytics can provide financial advisers with a more complete picture of their clients' financial lives, which in turn helps us monitor progress and adjust course as needed.

Clients want a trusted adviser to guide them in meeting their financial goals, and now I am able to implement new technologies that help me provide a higher level of service. Using new platforms, I am able to provide real-time information and advice to my clients. I can use this technology to tailor information to their specific investments, how the market is affecting them, and determine what moves to recommend to help them get them closer to their financial goals.

With recent volatility in the market, having immediate, real-time information helps me to change direction within a client's portfolio if needed, and has been a true blessing. The risk analytics platform enables me to identify financial risks that my clients may be exposed to and allows us to quickly change course if necessary. It's a powerful way to engage. Communicating expeditiously and efficiently is important with all clients including those that have large, diversified portfolios.

Lastly, as some clients mature in age, I have begun working with them and their adult children. Together, we use technology applications to monitor the portfolio's progress to meeting the client's goals. The technological tools available within the wealth management industry have become a beneficial way to conduct business with these younger generations, especially Millennials.

As the world continues to incorporate additional technologies into all facets of life, the new tools available to wealth managers can be impactful. We can improve our relationships with clients, provide dependable information, and help guide their decisions so they may achieve their goals in life.

------

Margo Geddie is senior vice president and financial adviser with the wealth management division of Morgan Stanley in Houston.

Trending News

Building Houston

 
 

You can now hop online and invest in this promising cell therapy startup. Photo via Getty Images

A clinical-stage company headquartered in Houston has opened an online funding campaign.

FibroBiologics, which is developing fibroblast cell-based therapeutics for chronic diseases, launched a campaign with equity crowdfunding platform StartEngine. The platform lets anyone — regardless of their net worth or income level — to invest in securities issued by startups.

The funding, according to a press release, will be used to support ongoing operations of Fibrobiologics and advance its clinical programs in multiple sclerosis, degenerative disc disease, wound care, extension of life, and cancer.

"We're excited to partner with StartEngine on this campaign. StartEngine has over 600,000 investors as part of their community and has raised over half a billion dollars for its clients," says FibroBiologics' Founder and CEO Pete O'Heeron, in the release.

"This is an exciting time at FibroBiologics as we continue progressing our clinical pipeline and developing innovative therapies to treat chronic diseases," he continues. "This new funding will fuel our growth in the lab and bring us one step closer to commercialization."

The campaign, launched this week, already has over 100 investors, at the time of publication, and has raised nearly $2 million, according to the page. The minimum investment is set at around $500, and the company's indicated valuation is $252.57 million.

In 2021, FibroBiologics announced its intention of going public. Last year, O'Heeron told InnovationMap on the Houston Innovators Podcast of the company's growth plans as well as the specifics of the technology.

Only two types of cells — stem cells and fibroblasts — can be used in cell therapy for a regenerative treatment, which is when specialists take healthy cells from a patient and inject them into a part of the body that needs it the most. As O'Heeron explains in the podcast, fibroblasts can do it more effectively and cheaper than stem cells.

"(Fibroblasts) can essentially do everything a stem cell can do, only they can do it better," says O'Heeron. "We've done tests in the lab and we've seen them outperform stem cells by a low of 50 percent to a high of about 220 percent on different disease paths."


Trending News